Ma. Marinella, REVERSIBLE HYPERKALEMIA ASSOCIATED WITH TRIMETHOPRIM-SULFAMETHOXAZOLE, The American journal of the medical sciences, 310(3), 1995, pp. 115-117
Trimethoprim-sulfamethoxazole (TMP-SMX) is a fixed-dose antimicrobial
agent used in a variety of infections, Adverse reactions are more comm
on in patients with AIDS, but occasionally occur in immunocompetent pa
tients, Renal toxicity is usually a hypersensitivity reaction to the s
ulfa component, and manifests as interstitial nephritis or sulfa cryst
allization in the renal tubules. Reversible hyperkalemia is a rarely r
eported side effect of TMP-SMX therapy attributed to TMP inhibition of
potassium secretion in the distal renal tubule in a manner similar to
the potassium sparing diuretic, amiloride. In this article, the autho
r reports a case of hyperkalemia associated with TMP-SMX occurring in
an elderly man with no other risk factors for hyperkalemia, which reso
lved upon discontinuation of the drug.